Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
- 11 June 2004
- Vol. 325 (2) , 425-431
- https://doi.org/10.1016/j.virol.2004.05.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypoxNature, 2004
- Intravenous immunoglobulin products contain neutralizing antibodies to vacciniaVox Sanguinis, 2004
- Antibody Neutralization of the Extracellular Enveloped Form of Vaccinia VirusVirology, 2001
- Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope AntigensVirology, 1999
- A Myristylated Membrane Protein Encoded by the Vaccinia Virus L1R Open Reading Frame Is the Target of Potent Neutralizing Monoclonal AntibodiesVirology, 1995
- Identification of a Vaccinia Virus Penetration ProteinVirology, 1994
- The Vaccinia Virus 42-kDa Envelope Protein Is Required for the Envelopment and Egress of Extracellular Virus and for Virus VirulenceVirology, 1993
- Significance of Extracellular Enveloped Virus in the in vitro and in vivo Dissemination of VacciniaJournal of General Virology, 1980
- An Antigenic Difference between Intracellular and Extracellular Rabbitpox VirusJournal of General Virology, 1971
- Complications of smallpox vaccination. Effects of vaccinia immune globulin therapyThe Journal of Pediatrics, 1965